Lipe & Dalton Exact Sciences Corp Transaction History
Lipe & Dalton
- $186 Million
- Q2 2024
A detailed history of Lipe & Dalton transactions in Exact Sciences Corp stock. As of the latest transaction made, Lipe & Dalton holds 9,020 shares of EXAS stock, worth $635,459. This represents 0.2% of its overall portfolio holdings.
Number of Shares
9,020
Previous 7,270
24.07%
Holding current value
$635,459
Previous $502,000
24.1%
% of portfolio
0.2%
Previous 0.26%
Shares
11 transactions
Others Institutions Holding EXAS
# of Institutions
637Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.28 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.16 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$1.04 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$850 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$578 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $12.5B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...